Case Study Archives

Case Study

Interim Pharmacokinetic Analysis to Enable Rapid Decision Making

View More

Case Study

Case Study – Clinical QT Prolongation Assessment

View More

Case Study

Navigating Regulatory Challenges: A Collaborative Journey to FDA Approval

View More

Case Study

Using PBPK to Predict CSF and Brain Exposure of CNS Penetrant Drugs

View More

Case Study

Unleashing the Power of Predictive Modeling: A Journey to Safe and Effective Dosing for a CNS Drug

View More

Case Study

Using PBPK to Optimize Magnesium Concentrations in an Intravenous Formulation

View More

Case Study

Development of a PK/PD Model for Gene Therapy for a Rare Neurodegenerative Disease

View More

Case Study

Due Diligence to Support a Client’s Decision-Making

View More

Case Study

Complex Concentration-QT Analysis

View More

Case Study

Grass & Birch Allergy Phase II Parallel Studies

View More

Solutions

Translational Clinical Pharmacology in Cell and Gene Therapy

Strengthen Your Regulatory Submissions Through Strategic Storyboarding

Therapeutic Expertise

Therapeutic Areas

Cross-Over Therapeutics

Advancing Oncology Research: Regulatory & Development Path for ADCs & Radionuclide Conjugates

Crossover Designs in Oncology: Statistical Perspectives

Company

Allucent Names Paula Brown Stafford as CEO Industry Veteran to Lead Next Phase of Global CRO’s Expansion

Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster Vaccines

Resources

Enabling Patient-Centric Drug Development: Opportunity for Clinical Pharmacology to Leverage Innovation and Advance Diversity and Inclusion in Clinical Trials

Achieving Operational Excellence in Clinical Research Organizations: A Catalyst for Biotech Success

Careers

Watch Our Corporate Video

Resources

Interim Pharmacokinetic Analysis to Enable Rapid Decision Making

Case Study – Clinical QT Prolongation Assessment

Navigating Regulatory Challenges: A Collaborative Journey to FDA Approval

Using PBPK to Predict CSF and Brain Exposure of CNS Penetrant Drugs

Unleashing the Power of Predictive Modeling: A Journey to Safe and Effective Dosing for a CNS Drug

Using PBPK to Optimize Magnesium Concentrations in an Intravenous Formulation

Development of a PK/PD Model for Gene Therapy for a Rare Neurodegenerative Disease

Due Diligence to Support a Client’s Decision-Making

Complex Concentration-QT Analysis

Grass & Birch Allergy Phase II Parallel Studies

Partner With the A-Team

Join the A-Team

Subscribe to our monthly newsletter